spec sheet11 rows
Dextromethorphan (DXM) is a morphinan cough suppressant that, at supratherapeutic doses, produces dose-dependent dissociative and hallucinogenic effects across successive intensity plateaus. Its complex pharmacology extends beyond antitussive activity: it is an uncompetitive N-methyl-D-aspartate (NMDA) glutamate receptor antagonist and a sigma-1 receptor agonist, and it additionally inhibits serotonin and norepinephrine reuptake and antagonises certain nicotinic acetylcholine receptors. This glutamatergic and sigma-1 activity underlies renewed therapeutic interest; the combination dextromethorphan/quinidine is approved for pseudobulbar affect, and the dextromethorphan/bupropion combination (AXS-05) demonstrated rapid antidepressant efficacy in randomised trials and gained approval for major depressive disorder, with bupropion serving to inhibit CYP2D6 metabolism and raise dextromethorphan exposure. Because it is widely available over the counter, dextromethorphan is prone to misuse, and combination cough products containing other actives add substantial toxicity risk.
- Cough suppression at normal doses
- Dose-dependent dissociation
- Euphoria and dreamlike states
- Distinctive 'plateau' structure
- Uncompetitive NMDA antagonist and sigma-1 agonist
- Nausea and vomiting
- Rapid heartbeat and high blood pressure
- Impaired coordination and 'robo-walk'
- Serotonin-syndrome risk with other serotonergics
Mechanism
At recreational doses dextromethorphan and its active dextrorphan act as non-competitive (N-methyl-D-aspartate) receptor antagonists, blocking the channel to produce dissociation. DXM is also a sigma-1 receptor and a (it blocks SERT and can raise serotonin), which is why it carries serotonin-syndrome risk. Its metabolism runs through the liver enzyme CYP2D6, so people who metabolize it slowly, or who take CYP2D6-inhibiting drugs, can reach much higher levels than expected.
receptor fingerprint
Non-competitive antagonist
Sigma-1 receptorAgonist
transporter (SERT)Reuptake inhibitor
Safetyrisks and cautions, not medical advice
The biggest hidden danger is combination products: DXM is often sold with acetaminophen (liver toxicity), antihistamines, or decongestants that become dangerous at the doses people take for effect, so only single-ingredient DXM is even remotely safer. Because DXM is serotonergic, combining it with MAOIs, SSRIs, or other serotonergic drugs can trigger serotonin syndrome, which is a medical emergency. High doses cause heavy dissociation, vomiting, rapid heartbeat and impaired coordination, and it should not be stacked with other depressants. Not medical advice.
Interactionsdocumented pairs only, not exhaustive
Dextromethorphan is extensively metabolized via the cytochrome P450 CYP2D6 isoenzyme, making it susceptible to metabolic interactions. Coadministration with potent CYP2D6 inhibitors including fluoxetine, paroxetine, and bupropion significantly prolongs dextromethorphan's half-life and elevates plasma concentrations. [10] [11] Bupropion combined with dextromethorphan (marketed as Auvelity) deliberately exploits this pharmacokinetic synergy; the CYP2D6 inhibition from bupropion maintains therapeutic dextromethorphan levels, allowing lower oral dosing than would otherwise be achievable. [12] Clinicians should monitor for increased adverse effects, including dissociation and dizziness, when dextromethorphan is used alongside other CYP2D6 inhibitors.
Serotonergic agents pose an additional concern given dextromethorphan's NMDA receptor antagonism and sigma-1 receptor activity; this combination warrants careful observation for signs of altered mood or cognition.
Checking a whole stack? Run it through interactions + stacks.
Subjective profileweighing the evidence above
Fine as a cough suppressant at label doses. Taken for effect it becomes a different drug, and the biggest danger is usually not the DXM but the acetaminophen or antihistamines in combination products; serotonergic medications make it genuinely dangerous.
Resources
This entry is here for reference.
Research
- 2007first citedDextromethorphan poisoning: an evidence-based consensus guideline for out-of-hospital management
- 2022most active year3 papers
- 2026most recentDXM, CYP2D6-inhibiting antidepressants, piracetam, and glutamine: proposing a ketamine-class an…
- 1.Pharmacology of dextromethorphan: Relevance to dextromethorphan/quinidine (Nuedexta®) clinical use
- 2.Dextromethorphan poisoning: an evidence-based consensus guideline for out-of-hospital management
- 3.A longitudinal study of cytochrome P450 2D6 (CYP2D6) activity during adolescence
- 4.Dextromethorphan/Bupropion: First Approval.
- 5.Efficacy and Safety of AXS-05 (Dextromethorphan-Bupropion) in Patients With Major Depressive Disorder: A Phase 3 Randomized Clinical Trial (GEMINI).
- 6.Dextromethorphan/quinidine pharmacotherapy in patients with treatment resistant depression: A proof of concept clinical trial.
- 7.Dextromethorphan/quinidine sulfate for pseudobulbar affect.
- 8.Effect of dextromethorphan/quinidine on pentylenetetrazole-induced clonic and tonic seizure thresholds in mice.
- 9.Over-the-counter Psychosis: A Systematic Review of the Misuse of Antihistamines, Cough Medicines, and Decongestants and the Risk of Developing Psychosis.
- 10.DXM, CYP2D6-inhibiting antidepressants, piracetam, and glutamine: proposing a ketamine-class antidepressant regimen with existing drugs.
- 11.The Black Book of Psychotropic Dosing and Monitoring.
- 12.Evaluation of dextromethorphan with select antidepressant therapy for the treatment of depression in the acute care psychiatric setting.
12 listed here; entry last updated August 2026
Reviews
My notesprivate to this device
FAQ
Which cold medicines are risky to use for DXM?
Any that combine DXM with acetaminophen, antihistamines, or decongestants; those extra ingredients become toxic at the amounts people take for dissociative effect.
Can DXM cause serotonin syndrome?
Yes. It inhibits serotonin reuptake, so combining it with MAOIs, SSRIs, or other serotonergic drugs can be dangerous or fatal.
Why do effects vary so much between people?
DXM is broken down by the CYP2D6 enzyme; poor metabolizers, or people on CYP2D6-blocking drugs, reach far higher levels from the same amount.
Adverse effects
- Nausea and vomiting
- Rapid heartbeat and high blood pressure
- Impaired coordination and 'robo-walk'
- Serotonin-syndrome risk with other serotonergics